header

Therapy related late effects in pediatric patients with hodgkin lymphoma treated with ABVD protocol at national cancer institute, Cairo University and children cancer ospital Egypt 57357 / (Record no. 78251)

MARC details
000 -LEADER
fixed length control field 03616cam a2200349 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field EG-GiCUC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250223032614.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201017s2020 ua dh f m 000 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EG-GiCUC
Language of cataloging eng
Transcribing agency EG-GiCUC
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title eng
049 ## - LOCAL HOLDINGS (OCLC)
Holding library Deposite
097 ## - Thesis Degree
Thesis Level Ph.D
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Cai01.19.05.Ph.D.2020.Mu.T
100 0# - MAIN ENTRY--PERSONAL NAME
Personal name Mustafa Mohamed Selim
245 10 - TITLE STATEMENT
Title Therapy related late effects in pediatric patients with hodgkin lymphoma treated with ABVD protocol at national cancer institute, Cairo University and children cancer ospital Egypt 57357 /
Statement of responsibility, etc. Mustafa Mohamed Selim ; Supervised Mohamed Hani Hussein , Iman Abdelmokhales Sidhom , Zeinab Salah Selim
246 15 - VARYING FORM OF TITLE
Title proper/short title ِِالأثار البعيدة المدى المرتبطة بعلاج الأطفال المصابين بورم هودجكين الغدد الليمفاوية وتم علاجهم ببرتوكول (إيه بى فى دى) فى المعهد القومى للأورام: جامعة القاهرة و مستشفى الأطفال مصر57573
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Cairo :
Name of publisher, distributor, etc. Mustafa Mohamed Selim ,
Date of publication, distribution, etc. 2020
300 ## - PHYSICAL DESCRIPTION
Extent 280 P. :
Other physical details charts , facimiles ;
Dimensions 25cm
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric oncology
520 ## - SUMMARY, ETC.
Summary, etc. Background/purpose Long-term Hodgkin Lymphoma (HL) survivors are at risk of developing a range of therapy-related complications that may present 10 -15 years after treatment. The primary goal of study is to estimate the frequency of late effects and to determine risk factors that may contribute to this. Methods We performed a cross-sectional study on HL survivors{u2019} who were treated at National Cancer Institute, Cairo or Children Cancer Hospital Egypt 57357 with ABVD chemotherapy ± radiotherapy with a minimum 5 years follow up. Results Two hundred and eight patients were candidate. The cumulative incidence (CI) of cardiac toxicity (CT) at 5 and 9 years was 18.7% ± SD 2.7 and 43.3% ± SD 4.4, respectively. Preexisting cardiac abnormalities, cumulative anthracycline dose and end of treatment cardiac status are a strong predictor for late cardiotoxicity. Hypertension, was observed in about 31% of HL survivors. Young age (prepuberty) and obesity at time of treatment are important factors for hypertension. Thyroid abnormalities developed with a 5-year CI of 2% (95% CI 0.6% - 4.9%) while at 9-years the CI was 27.9% (95% CI 19% - 36%). Neck radiation therapy and the percentage of thyroid gland exposed to radiation are important risk factors.Obesity, was observed in 36% of HL survivors. High body mass index and older age (post-puberty) at the initial presentation are significant factors for obesity during the follow up. Endocrine hypogonadism was present in 22.5% of male survivors and 38% of female survivors. Disturbance of menstrual cycles was XII present in about one-third of female survivors. Furthermore, exposure to radiation therapy was associated with higher risk of irregular menstrual cycles. Abnormal pulmonary function tests were found in 43% and restrictive pattern was the most common type. Secondary cancers were founded in 3 patients (1.4%)
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Issued also as CD
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Hodgkin Lymphoma survivors
653 #4 - INDEX TERM--UNCONTROLLED
Uncontrolled term Late effects
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Iman Abdelmokhales Sidhom ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Mohamed Hani Hussein ,
Relator term
700 0# - ADDED ENTRY--PERSONAL NAME
Personal name Zeinab Salah Selim ,
Relator term
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a>
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Nazla
Reviser Revisor
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN)
Cataloger Shimaa
Reviser Cataloger
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Thesis
Holdings
Source of classification or shelving scheme Not for loan Home library Current library Date acquired Full call number Barcode Date last seen Koha item type Copy number
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة قاعة الرسائل الجامعية - الدور الاول 11.02.2024 Cai01.19.05.Ph.D.2020.Mu.T 01010110081746000 22.09.2023 Thesis  
Dewey Decimal Classification   المكتبة المركزبة الجديدة - جامعة القاهرة مخـــزن الرســائل الجـــامعية - البدروم 11.02.2024 Cai01.19.05.Ph.D.2020.Mu.T 01020110081746000 22.09.2023 CD - Rom 81746.CD